Influenza A virus A/Victoria/361/2011 (H3N2) recombinant hemagglutinin antigen Recruiting Phase 4 Trials for Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukemia (AML) Supportive Care

IndicationsStatusPurposePhase
RecruitingSupportive Care4
clinicaltrials.gov IdentifierTitleDrugs
NCT04484532Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers